Professional Documents
Culture Documents
Cardiovascular Alterations in the Parturient Undergoing Cesarean Delivery With Neuraxial Anesthesia
Pembimbing
Kepanitraan Klinik Anestesi Rumah Sakit Otorita Batam Periode 18 Juni 21 Juli 2012 Fakultas Kedokteran Universitas Trisakti
LEMBAR PENGESAHAN
Journal Reading Ilmu Anestesi dengan judul :
Cardiovascular Alterations in the Parturient Undergoing Cesarean Delivery With Neuraxial Anesthesia
Nama NIM
: :
Telah diterima dan disetujui oleh pembimbing Dr. M. Gusno Rekozar, Sp.An pada :
Hari Tanggal
: :
Sebagai salah satu syarat dalam mengikuti dan menyelesaikan Kepaniteraan Klinik Ilmu Anestesi Di Rumah Sakit Otorita Batam
Cardiovascular Alterations in the Parturient Undergoing Cesarean Delivery With Neuraxial Anesthesia
Abstract and Introduction
Abstract
Sewaktu melahirkan melalui sectio caesaria dengan anestesi neuroaxial, hemodinamik si ibu berubah akibat pemberian cairan intravena, onset masa blok, dan sewaktu kelahiran bayi. Derajat perubahan hemodinamik ini dipengaruhi oleh beberapa faktor yang saling berinteraksi, seperti perubahan anatomi dan fisiologi saat kehamilan, faktor ibu, dan faktor janin. Selain itu, faktor comorbid, teknik neuroaksial, banyaknya kehilangan darah dan cairan, serta tatalaksana pengobatan juga berpengaruh. Saat ini faktor-faktor yang mempengaruhi hemodinamik, teknik anestesia, cara mencegah dan mengatasi hipotensi,akan dibahas untuk melihat perubahan kardiovaskuler pada saat partus melalui sectio caesaria dengan anestesia neuroaxial.
Introduction
Rasio partus melalui sectio caesaria telah meningkat dari 4,5 % (1965) mejadi 32,3 % di tahun 2008..[1] di banyak negara berkembang, penggunaan anestesi neuroaxial (epidural, spinal maupun kombinasi keduanya) sangat banyak digunakan. Karakter ibu dan janin, fator comorbid, perubahan anatomi dan fisiologi saat kehamilan, tatalaksana obat dan cairan, serta dampak dari pembedahan dan anestesi akan berpengaruh besar terhadap respons kardiovaskular. Derajat perubahan saat kehamilan dan partus sectio akan diuji. Dengan pengetahuan di ilmu kedokteran, kita akan mengevaluasi perubahan kardiovaskular, termasuk partus dengan preeklampsia ataupun kehamilan multifetal. Akhirnya, metode untuk mencegah dan mengatasi hipotensi akibat teknik spinal akan dibahas.
assumptions. The risk of foreshortening the right ventricle can be reduced, [30] which may be of particular benefit to the parturient with congenital heart disease or whose right ventricle is strained secondary to increased CO or increased pulmonary vascular resistance. [31] 3DE speckle tracking algorithms, which track the motion of speckles within the scan volume, further improve the visual geometric border detection of the ventricle, an inherent limitation in determining the shape and size of the ventricle.[34] This modality shows good intra- and inter-observer reliability, as well as testretest reliability for routine evaluation of ejection fraction and left ventricular volumes. [29] 3DE direct volumetric and speckle-tracking methods appear to provide comparable and reproducible results of ventricular volume and function, and are both feasible options for routine clinical practice. [32,33] In 1966, impedance cardiography was introduced in which changes in the electrical impedance across the thorax or whole body throughout the cardiac cycle were analyzed; from these measurements, CO is calculated. However, CO obtained by impedance cardiography correlates poorly with thermodilution measurements during CD[20] and during pregnancy in the presence of hypertensive diseases.[35] The overall accuracy of this technique in healthy term pregnancies has therefore been questioned.[36] Despite this, the method may be valuable for producing noninvasive, continuous data to detect CO trends.[37,38] Consequently, in Table 2 & Table 3, the data obtained through this technique[39,40] may not be as accurate as those obtained through other techniques. Modern devices have been developed that continuously measure CO using information derived from an arterial line such as the FloTrac (Flo Trac/Vigileo, Edwards Lifesciences, CA, USA), PiCCO (Pulsion Medical Systems AG, Munich, Germany) and LiDCO (PulseCO system, LiDCO Ltd, Cambridge, UK). The LiDCO device can be used with a peripheral venous and a radial arterial line and has the advantage of measuring beat-to-beat CO measurements, making it an excellent tool for measuring trends. A study employing bioimpedance and LiDCO measurements in the same patient found similar trends in changes in CO in response to spinal anesthesia and vasopressor administration.[41] A recent study also found acceptable agreement between thermodilution and LiDCO measurement immediately postpartum in pre-eclamptic patients.[42] Although studies have been performed that evaluate the clinical application of these devices, [43] further validation in pregnancy is necessary.
maximal uterine artery blood flow has been observed with prehydration despite the absence of maternal MAP increases.[50] It has been suggested that the prevention of neuraxial anesthesia-induced hypotension is dependent on a fluid bolus sufficient enough to significantly increase intravascular volume, and subsequently CO.[51] Rapid administration of fluid in term parturients prior to neuraxial techniques does increase CO; however, the response is dependent on alterations in HR and SV that are quite variable. One study demonstrated that the administration of 1 l of lactated Ringers (LR) solution 15 min prior to neuraxial anesthesia increased CO by 20% (from 6.50 to 7.83 l/min), with the HR increasing from 77.6 to 81.9 bpm and the SV increasing from 84.2 to 95.4 ml.[52] A second study, using LR solution in a mean volume of 805 ml as prehydration, observed a 10% increase in CO (from 7.01 to 7.70 l/min) with a relatively stable HR (8382 bpm) but a significant increase in SV from 84 to 95 ml.[53] A similar study using 1 l of LR as prehydration resulted in an 11% increase in CO (5.25.8 l/min), an unchanged HR and a significant increase in SV from 63.3 to 70.5 ml.[54] A final study using 10 ml/kg of 6% hydroxyethyl starch (HES) as prehydration noted an increase in CO (cardiac index increasing 12% from 3.2 to 3.6 l/min/m2) and HR (7489 bpm), but a decreasing stroke index from 42.2 to 40.2 ml/m2.[40] Summarizing these studies, an increase in CO is observed with prehydration; however, the relative contributions of HR and SV are variable. The magnitude of CO increase is related to the fluid type, as well as the amount of hydration. Furthermore, the amount of fluid that remains intravascular may be associated with the incidence of hypotension. In a study comparing 1.5 l LR to 0.5 l HES to 1 l HES as prehydration prior to neuraxial blockade for CD, Ueyama and colleagues demonstrated that the amount of prehydration that remains intravascular (as measured by indocyanine green blood concentration monitored though noninvasive pulse spectrophotometry) is significantly correlated to the increase in CO; moreover, the incidence of hypotension was reduced in the group with the greatest increase in CO. [51] The authors demonstrated that in the 1.5 l LR, 0.5 l HES and 1.0 l HES groups, the volume of infused solution remaining in the intravascular space was 0.43 0.20 l, 0.54 0.14 l and 1.03 0.21 l, respectively; and the increase in CO was 11% (from 5.4 1.0 to 6.0 1.0 l/min), 15% (from 5.4 1.0 to 6.2 0.6 l/min) and 43% (from 5.1 1.0 to 7.3 1.1 l/min), respectively. The percentage of blood volume increase significantly correlated to the increase in CO (r2 = 0.838; p < 0.001). The incidence of hypotension after spinal anesthesia was 75% in the 1.5 l LR group, 58% for the 0.5 l HES group and only 17% for the 1.0 l HES group. In summary, 1.0 l of HES preload increased the intravascular volume and CO significantly more effectively than 1.5 l LR or 0.5 l HES; the incidence of 1 h post spinal hypotension was also reduced in this group. Overall, colloid solutions have been found to be more effective than crystalloid solutions in prehydration to prevent hypotension,[55] especially when at least 1 l of HES is used.[51] However, the use of colloid solutions prior to uterine evacuation and subsequent autotransfusion has been questioned by some, with the risk of potential pulmonary edema, allergies to colloidal solutions and the costs of the solutions cited.[56] Interestingly, recent studies have demonstrated that initiating a rapid infusion of crystalloid at the time of neuraxial blockade administration (i.e., 'co-loading') is as effective as prehydration with crystalloid in preventing hypotension; [45,57]however, when colloid is used as a coload versus for prehydration, there are no differences in the incidence of hypotension or vasoactive medications use.[48,58] Therefore, crystalloid solutions are more beneficial in preventing hypotension when used as a co-load instead of as prehydration, whereas colloid solutions can be as beneficial when used in either of these time frames. As a result of these studies, the use of a rapid co-load of crystalloid solution through a moderately large intravenous line during performance of a neuraxial technique for CD is a viable option.
removal of fetal heart rate monitors for skin sterilization of the abdomen, systolic blood pressure (SBP) is typically maintained within 20% of baseline values, or above a SBP of 100 mmHg (a common research definition of hypotension). Hypotension is typically poorly tolerated in parturients, often resulting in nausea, vomiting and lightheadedness. Spinal-induced hypotension in parturients undergoing CD is frequent, with reported incidences ranging from 17 to 95%.[51,67] The associated maternal and fetal morbidity and mortality associated with hypotension have investigators seeking clinically feasible and reliable ways to predict which parturients are at greatest risk.[6870] Maternal HR variability as a measure of autonomic nervous system activity appears promising in predicting hypotension risk.[7174] The most effective strategies for prevention of spinal-induced hypotension include prehydration with a sufficient amount of colloid[51] or co-loading with sufficient crystalloid,[45] positioning the parturient for surgery in the left uterine displacement position,[75] using a lower dose of intrathecal bupivacaine,[63,76 78] and administering prophylactic vasoactive agents such as ephedrine or phenylephrine. [63,79,80] Each of these strategies will be reviewed, with their relative efficacy summarized (Box 1).
receptors such as baroreceptors in the right atrium, mechanoreceptors in the left ventricle, or receptors in cardiac pacemaker cells leading to a decrease in HR; this mechanism is supported by the observation that HR decreases in transplanted hearts after spinal anesthesia. [94] In summary, the effect of intrathecal local anesthetic on HR most often depends upon the height of the block; blocks extending to the first through fourth thoracic sympathetic spinal levels affect the cardiac acceleration fibers and potentially cause bradycardia. A study has shown that increased doses of intrathecal hyperbaric bupivacaine increase the likelihood of bradycardia.[76]
values).[66] The latter values were originated in a study where uterine displacement was not used, likely exaggerating the removal of uterine aortocaval compression upon delivery.
Multifetal Gestation
Multifetal gestation introduces a number of hemodynamic derangements. Twin gestations are associated with a 10% greater increase in maternal blood volume[124] and a 20% greater increase in CO than a singleton pregnancy.[125] The diastolic blood pressure of parturients with twin gestations is associated with a lower nadir during the second trimester and greater increases as the third trimester progresses when compared with a singleton pregnancy. [126] Aortocaval compression is more common because of the greater uterine size, and blood loss with delivery is greater. Because of these exaggerated hemodynamic variables, parturients with multifetal gestations were believed to experience greater hemodynamic instability during CD under neuraxial anesthesia. However, a recent prospective study observed that parturients with multifetal gestation undergoing spinal anesthesia for CD did not have a greater incidence of hypotension or vasopressor requirements in comparison with parturients with singleton gestations.[127]
Vasopressors
Healthy pregnant women have a diminished response to vasopressor administration, which can result in relatively greater dosage requirements than nonpregnant patients. However, ephedrine, phenylephrine and dopamine can all prevent spinal anesthesia-induced hypotension better than placebo,[135138] which has encouraged some practitioners to utilize prophylaxis instead of treatment only, to mitigate the effects of hypotension. The selection of a vasopressor for the prophylaxis or treatment of spinal hypotension has been a subject of a number of investigations and several current comprehensive reviews. [139,140] Recent studies have indicated that neuraxial anesthesia, particularly spinal anesthesia, may be associated with decreased fetal umbilical cord pH readings.[141143] Historical evidence that vasopressors with predominant -adrenergic stimulation resulted in uteroplacental vasoconstriction [144147] led many anesthesiologists to avoid phenylephrine. Ephedrine, in contrast to -agonists, demonstrated greater
selectivity of systemic over uterine blood vessel constriction, [148] and was shown to improve maternal blood pressure and uteroplacental blood flow during spinal anesthesia. [149,150]Ephedrine was subsequently considered the vasopressor of choice to prevent or treat hypotension during neuraxial anesthesia for CD. However, recent evidence has suggested that previous concerns regarding uteroplacental vasoconstriction with the use of phenylephrine may have been overstated, whereas the detrimental effects of ephedrine to the fetus may have been understated.[151] The concern with ephedrine in the obstetric population is an association with fetal acidosis and decreases in fetal base excess,[151154] possibly in a dose-dependent manner.[155] In 104 parturients undergoing spinal anesthesia for elective CD randomized to receive an infusion of phenylephrine or ephedrine,[151] fetuses exposed to ephedrine demonstrated significantly lower pH and base excess, and significantly higher umbilical arterial and venous partial pressure CO 2, lactate, glucose and norepinephrine concentrations. Most interesting, the mean umbilical venous to maternal artery (UV/MA) plasma concentration ratios were significantly greater in the ephedrine group (1.13 vs 0.17), indicating ephedrine's greater ability to cross the placenta. In addition, the umbilical artery to umbilical venous (UA/UV) plasma concentration ratios were also significantly greater with ephedrine (0.83 vs 0.71), indicating that ephedrine likely undergoes less early metabolism and redistribution in the fetal plasma. The greater presence in fetal circulation thus results in an increase in fetal metabolism. Multiple recent studies have indicated that phenylephrine is more effective with lesser fetal acid base alterations than ephedrine when used either as prophylaxis or treatment for hypotension in both elective and nonelective cesarean deliveries.[153,156] A randomized double-blinded comparison study of phenylephrine and ephedrine, and their combinations, indicated that decreasing proportions of phenylephrine were associated with worse hemodynamic control and fetal acid-base status.[157] The weight of the evidence for phenylephrine use for neuraxial anesthesia-induced hypotension during CD has now appeared to equal 'the burden of proof'.[158]However, in high-risk patients with significant hypertensive disease of pregnancy, comorbid conditions affecting placental physiology, or, in the cases of emergency CD, with impaired or at-risk fetuses, there are insufficient data to support its safety, and there may be some cause for concern.[159] Further investigations will be necessary to determine the role of -adrenergic agonists versus other vasopressor agents in these settings. The efficacy of prophylactic phenylephrine in preventing spinal hypotension is undoubted. A prophylactic phenylephrine infusion, particularly when combined with crystalloid co-hydration, is highly effective in maintaining hemodynamic stability. Ngan Kee and colleagues observed that an intravenous infusion of phenylephrine 100 mcg/min titrated with blood pressure readings carried out each minute nearly eliminated hypotension (defined as SBP <80% baseline) in nonlaboring parturients undergoing spinal anesthesia for elective CD.[160] Although hypotension occurred in 15 subjects (28.3%; 95% CI: 18.041.6%) in the maintenance fluid group (n = 55), only one subject (1.9%; 95% CI: 0.39.9%) experienced this in the rapid infusion crystalloid group (n = 57). Determining the precise dosing regimen for phenylephrine to consistently prevent spinal hypotension while minimizing episodes of undertreatment (hypotension and/or nausea) or over-treatment (hypertension and/or bradycardia) has been recently extensively studied. [80,157,160163] One study indicates that a fixed rate of 75 or 100 mcg/min phenylephrine is associated with more episodes of hypertension (than placebo or rates of 25 or 50 mcg/min) and a 100 mcg/min infusion was associated with episodes of sinus bradycardia requiring treatment with glycopyrrolate. [164] Citing a study that shows that bolus phenylephrine reduces maternal CO in close correlation to maternal HR,[41] other experts feel that phenylephrine can be administered in bolus doses titrated to maintain a stable HR. This, in turn, will maintain an adequate SVR to maintain a stable maternal MAP.[65]
Conclusion
Variables that contribute to the hemodynamic changes observed in parturients undergoing CD with neuraxial anesthesia include hydration; maternal positioning during and after the block; the block type, height and density; the presence of hypertensive disorders of pregnancy; gestational age; the number of gestations; the presence of labor; and the prophylactic or therapeutic use of vasoactive substances. The most effective strategies for prevention of neuraxial-induced hypotension include prehydration with a sufficient amount of colloid or co-loading with sufficient crystalloid or colloid, positioning the parturient for surgery in the left uterine displacement position, using a lower dose of intrathecal bupivacaine, and most notably, administering a prophylactic vasoactive agent such as phenylephrine. An understanding of how each contributing variable contributes to the overall hemodynamic picture will assist the anesthesiologist in predicting, preventing or treating hemodynamic changes that occur during cesarean delivery with neuraxial anesthesia. Mitigating these hemodynamic alterations may ultimately improve the safety and side-effect profile for the mother undergoing cesarean delivery and her baby.
Expert Commentary
Over the past 10 years, clinician-scientists have artfully performed a series of clinical studies that have assisted the clinician in preventing neuraxial anesthesia-induced hypotension. Although left uterine displacement has been utilized for decades, the mode of hydration has changed from administration of a fluid bolus prior to initiation of neuraxial anesthesia, to simply co-loading fluid as the neuraxial technique is being performed. Lower doses of intrathecal local anesthesia supplemented with opioid are now being used and phenylephrine has replaced ephedrine as the vasopressor of choice. The phenylephrine infusion regimens are now widely employed clinically, with clinicians experiencing far fewer episodes of post-neuraxial anesthesia-induced hypotension.
Five-year View
Advances in invasive, and particularly noninvasive, methods of CO measurement will allow improved monitoring of the parturient undergoing CD. In the next 5 years, these methods of monitoring CO will undergo further evaluation, validation and application in research and clinical environments. Improved hemodynamic monitoring should allow better understanding, titration and timing of vasopressor and fluid regimens in the parturient undergoing cesarean delivery. Ultimately, this may mitigate some of the hemodynamic variations associated with neuraxial techniques and improve known and unknown maternal and fetal parameters associated with favorable outcomes.